Authors:
Venturini, M
Michelotti, A
Papaldo, P
Del Mastro, L
Bergaglio, M
Lionetto, R
Lunardi, G
Sguotti, C
Frevola, L
Donati, S
Rosso, R
Cognetti, F
Citation: M. Venturini et al., Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients, ANN ONCOL, 12(8), 2001, pp. 1097-1106
Authors:
Carlini, P
Frassoldati, A
De Marco, S
Casali, A
Ruggeri, EM
Nardi, M
Papaldo, P
Fabi, A
Paoloni, F
Cognetti, F
Citation: P. Carlini et al., Formestane, a steroidal aromatase inhibitor after failure of non-steroidalaromatase inhibitors (anastrozole and letrozole): Is a clinical benefit still achievable?, ANN ONCOL, 12(11), 2001, pp. 1539-1543
Authors:
Venturini, M
Michelotti, A
Papaldo, P
Del Mastro, L
Bergaglio, M
Lionetto, R
Lunardi, G
Sguotti, C
Frevola, L
Donati, S
Rosso, R
Cognetti, F
Citation: M. Venturini et al., Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients. (vol 12, pg 1097, 2001), ANN ONCOL, 12(10), 2001, pp. 1498-1498
Authors:
Ferraresi, V
Milella, M
Vaccaro, A
D'Ottavio, AM
Papaldo, P
Nistico, C
Thorel, MF
Marsella, A
Carpino, A
Giannarelli, D
Terzoli, E
Cognetti, F
Citation: V. Ferraresi et al., Toxicity and activity of docetaxel in anthracycline-pretreated breast cancer patients - A phase II study, AM J CL ONC, 23(2), 2000, pp. 132-139
Authors:
Mottolese, M
Benevolo, M
Del Monte, G
Buglioni, S
Papaldo, P
Nistico, C
Di Filippo, F
Vasselli, S
Vici, P
Botti, C
Citation: M. Mottolese et al., Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy, J CANC RES, 126(12), 2000, pp. 722-729
Authors:
Campisi, C
Fabi, A
Papaldo, P
Tomao, S
Massidda, B
Zappala, A
Ionta, MT
Cognetti, F
Citation: C. Campisi et al., Ifosfamide given by continuous-intravenous infusion in association with vinorelbine in patients with anthracycline-resistant metastatic breast cancer: A phase I-II clinical trial, CANC CHEMOT, 44, 1999, pp. S1-S4
Authors:
Milella, M
Nistico, C
Ferraresi, V
Vaccaro, A
Fabi, A
D'Ottavio, AM
Botti, C
Giannarelli, D
Lopez, M
Cortesi, E
Foggi, CM
Antimi, M
Terzoli, E
Cognetti, F
Papaldo, P
Citation: M. Milella et al., Breast cancer and timing of surgery during menstrual cycle: a 5-year analysis of 248 premenopausal women, BREAST CANC, 55(3), 1999, pp. 259-266